Heart Failure Treatments

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 201...

August 28, 2014 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with heart failure or atrioventricular (AV) block.

July 18, 2014 — The Freedom portable driver has received U.S. Food and Drug Administration (FDA) approval for use with the SynCardia temporary total artificial heart as a bridge to transplantation in cardiac transplant candidates who are clinicall...

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for adults over the age of 65 in the United States and...

October 1, 2014 — Heart Hospital of Austin is the first facility in Texas to implant a new miniaturized, wireless monitoring sensor to manage heart...
heartmate III, tohratec, heart failure, heart failure treatment
Thoratec Corporation announced that it has begun to enroll patients in the HeartMate III U.S. clinical trial. 
VADs Gain Popularity Artificial Hearts Remain Ideal GlobalData
Robert Littlefield, MSc, GlobalData's senior analyst covering Medical Devices, said: “Since the first implantation of the Jarvik 7 in 1982, artificial...
Unexpected trips to the hospital are inconvenient and worrisome for anyone, but for congestive heart failure sufferers, they can be all too frequent.
SynCardia Total Artificial Heart SynHall Valves FDA approval
SynCardia SynHall valves, use in the SynCardia Heart, are of the same design, materials and nearly identical manufacturing processes as the
The Freedom portable driver is U.S. Food and Drug Administration (FDA)-approved for use with the SynCardia temporary total artificial heart...
The CardioMEMS Heart Failure System is the firstU.S. Food and Drug Administration (FDA)-approved heart failure (HF) monitoring device shown...
Boston Scientific Corp. received U.S. Food and Drug Administration (FDA) approval for its latest generation of defibrillators and heart...

Articles

VADs Gain Popularity Artificial Hearts Remain Ideal GlobalData
Robert Littlefield, MSc, GlobalData's senior analyst covering Medical Devices, said: “Since the first implantation of the Jarvik 7 in 1982, artificial...
September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease...
Syncardiac, driver, artificial heart
July 18, 2014 — The Freedom portable driver has received U.S. Food and Drug Administration (FDA) approval for use with the SynCardia temporary total artificial...
In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
4 days 23 hours ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
3 weeks 6 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
9 weeks 5 days ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...

Comparison Charts

Sorry there is no data available